RELFLAYRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Jul 2022)
What this means for you
This application is over — abandoned 11 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88797027
- Mark type
- Stylized text
- Filed
- 13 Feb 2020
- Published for opposition
- 14 Apr 2020
- Abandoned
- 11 Jul 2022
- Attorney of record
- Louis C. Cullman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances for the treatment of dryness of the eye or dry eye flares; topical ophthalmic pharmaceutical preparations and substances for temporal relief of the signs and symptoms of dry eye disease or dry eye flares
Owner
- Kala Pharmaceuticals, Inc., Watertown, MA, US
- Kala Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 11 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2021 — SOU EXTENSION 3 GRANTED
- 01 Dec 2021 — SOU EXTENSION 3 FILED
- 01 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jun 2021 — SOU EXTENSION 2 GRANTED
- 02 Jun 2021 — SOU EXTENSION 2 FILED
- 02 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2020 — SOU EXTENSION 1 GRANTED
- 01 Dec 2020 — SOU EXTENSION 1 FILED
- 01 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT